Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,125 USD | -1,32% | -26,95% | +65,44% |
01/04 | IMUNON, INC. : Een koopadvies van HC Wainwright | ZM |
28/03 | Top stijgers in de middag | MT |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 10,57 mln. 9,94 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,61 mln. | Nettowinst (verlies) 2025 * | -26 mln. -24,43 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,5
x | K/w-verhouding 2025 * |
-0,66
x | Werknemers | 33 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 98,85% |
Recentste transcriptie over Imunon, Inc.
1 dag | -1,32% | ||
1 week | -26,95% | ||
Lopende maand | -31,40% | ||
1 maand | +36,36% | ||
3 maanden | +90,65% | ||
6 maanden | +11,39% | ||
Lopend jaar | +65,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 03-01-07 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 06-07-10 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 11/12 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 56 | 08-06-21 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 08-07-11 |
James Dentzer
BRD | Director/Board Member | 57 | 03-10-22 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 1,125 | -1,32% | 198 926 |
17-04-24 | 1,14 | -16,79% | 149 608 |
16-04-24 | 1,37 | -6,80% | 94 992 |
15-04-24 | 1,47 | -7,55% | 126 431 |
12-04-24 | 1,59 | +3,25% | 159 162 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+65,44% | 10,72 mln. | |
-3,30% | 102 mld. | |
+1,79% | 96,84 mld. | |
-0,44% | 21,48 mld. | |
-18,35% | 20,82 mld. | |
-7,45% | 18,6 mld. | |
-40,31% | 16,81 mld. | |
-26,84% | 13,78 mld. | |
+0,59% | 13,4 mld. | |
+20,86% | 11,06 mld. |